Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia.
Brøsen JMB, Agesen RM, Kristensen PL, Alibegovic AC, Andersen HU, Beck-Nielsen H, Gustenhoff P, Hansen TK, Hedetoft C, Jensen T, Stolberg CR, Juhl CB, Lerche SS, Nørgaard K, Parving HH, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U. Brøsen JMB, et al. Among authors: hansen tk. Diabetes Obes Metab. 2023 Jun;25(6):1557-1565. doi: 10.1111/dom.15003. Epub 2023 Feb 28. Diabetes Obes Metab. 2023. PMID: 36749303 Clinical Trial.
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia.
Brøsen JMB, Agesen RM, Alibegovic AC, Andersen HU, Beck-Nielsen H, Gustenhoff P, Hansen TK, Hedetoft C, Jensen TJ, Juhl CB, Stolberg CR, Lerche SS, Nørgaard K, Parving HH, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U. Brøsen JMB, et al. Among authors: hansen tk. J Diabetes Sci Technol. 2023 Sep 6:19322968231197423. doi: 10.1177/19322968231197423. Online ahead of print. J Diabetes Sci Technol. 2023. PMID: 37671755
Hypoglycemia event prediction from CGM using ensemble learning.
Fleischer J, Hansen TK, Cichosz SL. Fleischer J, et al. Among authors: hansen tk. Front Clin Diabetes Healthc. 2022 Dec 9;3:1066744. doi: 10.3389/fcdhc.2022.1066744. eCollection 2022. Front Clin Diabetes Healthc. 2022. PMID: 36992787 Free PMC article.
Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach.
Brønden A, Christensen MB, Glintborg D, Snorgaard O, Kofoed-Enevoldsen A, Madsen GK, Toft K, Kristensen JK, Højlund K, Hansen TK, Søndergaard E, Hansen KB. Brønden A, et al. Among authors: hansen tk. Diabet Med. 2023 Aug;40(8):e15157. doi: 10.1111/dme.15157. Epub 2023 Jun 12. Diabet Med. 2023. PMID: 37249579 Review.
Patient-reported outcome (PRO) measurements in chronic and malignant diseases: ten years' experience with PRO-algorithm-based patient-clinician interaction (telePRO) in AmbuFlex.
Hjollund NHI, Larsen LP, de Thurah AL, Grove BE, Skuladottir H, Linnet H, Friis RB, Johnsen SP, May O, Jensen AL, Hansen TK, Taarnhøj GA, Tolstrup LK, Pappot H, Ivarsen P, Dørflinger L, Jessen A, Sørensen NT, Schougaard LMV, Team TA. Hjollund NHI, et al. Among authors: hansen tk. Qual Life Res. 2023 Apr;32(4):1053-1067. doi: 10.1007/s11136-022-03322-9. Epub 2023 Jan 13. Qual Life Res. 2023. PMID: 36639598 Free PMC article.
Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes.
Voigt JH, Lauritsen KM, Pedersen SB, Hansen TK, Møller N, Jessen N, Laurenti MC, Dalla Man C, Vella A, Gormsen LC, Søndergaard E. Voigt JH, et al. Among authors: hansen tk. Basic Clin Pharmacol Toxicol. 2024 May;134(5):643-656. doi: 10.1111/bcpt.13991. Epub 2024 Feb 26. Basic Clin Pharmacol Toxicol. 2024. PMID: 38409617 Clinical Trial.
212 results